|
Resverlogix Presents at Clinical Trials in Alzheimer’s Disease (CTAD) Asia 2018
|
5
|
Resverlogix Corp.
|
Sep 04, 2018 08:54AM
|
|
Re: Resverlogix Presents at Clinical Trials in Alzheimer’s Disease (CTAD) Asia 2018
|
7
|
Resverlogix Corp.
|
Sep 04, 2018 08:58AM
|
|
Re: Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study
|
3
|
Zenith Epigenetics
|
Sep 04, 2018 09:05AM
|
|
Re: Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study
|
7
|
Zenith Epigenetics
|
Sep 04, 2018 09:46AM
|
|
DESIGN AND CHARACTERIZATION OF NOVEL COVALENT BROMODOMAIN AND EXTRA-TERMINAL DOMAIN (BET) INHIBITORS TARGETING A METHIONINE
|
7
|
Zenith Epigenetics
|
Sep 04, 2018 10:23AM
|
|
Re: Resverlogix Presents at Clinical Trials in Alzheimer’s Disease (CTAD) Asia 2018
|
3
|
Resverlogix Corp.
|
Sep 04, 2018 01:01PM
|
|
Re: Resverlogix H2 2018 events
|
5
|
Resverlogix Corp.
|
Sep 04, 2018 03:44PM
|
|
Re: (one) case study
|
3
|
Zenith Epigenetics
|
Sep 04, 2018 07:54PM
|
|
Re: Melanotransferrin receptor vs. Transferrin Recepor
|
5
|
BIOASIS TECHNOLOGIES INC
|
Sep 04, 2018 11:50PM
|
|
Re: Short Interest in RVXCF at new recent high
|
7
|
Resverlogix Corp.
|
Sep 05, 2018 01:24PM
|
|
Re: Here's to New 52 week highs
|
3
|
Resverlogix Corp.
|
Sep 05, 2018 01:41PM
|
|
Re: 8 year high
|
4
|
Resverlogix Corp.
|
Sep 05, 2018 02:48PM
|
|
Re: Here's to New 52 week highs
|
2
|
Resverlogix Corp.
|
Sep 06, 2018 09:47AM
|
|
Re: Naz listing requirements....
|
5
|
Resverlogix Corp.
|
Sep 06, 2018 10:48AM
|
|
Re: Naz listing requirements....
|
4
|
Resverlogix Corp.
|
Sep 06, 2018 02:01PM
|
|
Re: Stockhouse posters.....
|
3
|
Resverlogix Corp.
|
Sep 07, 2018 10:23AM
|
|
Re: ZENITH at 2.00
|
1
|
Resverlogix Corp.
|
Sep 07, 2018 10:23AM
|
|
Re: NYC events
|
3
|
Resverlogix Corp.
|
Sep 07, 2018 02:26PM
|
|
Re: Spike
|
3
|
Resverlogix Corp.
|
Sep 08, 2018 08:59PM
|
|
Re: Spike
|
4
|
Resverlogix Corp.
|
Sep 09, 2018 08:33AM
|
